OR-RADISYS
25.2.2022 18:02:10 CET | Business Wire | Press release
Radisys® Corporation , a global leader of open telecom solutions, today announced a showcase of its end-to-end open telecom and digital engagement portfolio at MWC Barcelona 2022 in Booth 5B81. Following the successful disaggregation of the flagship Media Server which is currently operating in over 200 networks, Radisys is extending the principles of disaggregation across both fixed and mobile broadband access offerings. Radisys’ Software-centric Network Functions, complemented by Open Hardware components, are now ready for operators to deploy to begin accruing the benefits of modern network architectures. Complementing these offerings, the focus on monetization leverages the power of computing-at-the-edge and offers new revenue opportunities.
Disaggregation of 5G and FTTX Access Networks
- Radisys will demonstrate 5GNR solutions enabled with its Release 16 compliant 5G software and systems integration capabilities. Attendees will learn how Radisys with its ecosystem partners is enabling a diverse customer base in the 5G space for CSPs, private networks and other market verticals. The 5G Innovation Showcase will include a 5G Small Cell demonstration with highly optimized architecture and low footprint and a network-in-a-box demonstration with 5G vRAN protocol software.
- Radisys will demonstrate its open, disaggregated, cloud native PON solution with the flexibility and scalability to transform FTTX networks. Attendees will see triple-play services over XGS-PON with Radisys’ Combo PON OLTs (simultaneous G-PON and XGS-PON support).
- Radisys is actively participating in the SD-RAN and VOLTHA demonstrations with ONF. Meet Radisys at the ONF Pavilion Hall 1 (Booth 1F66).
Broadband-everywhere
- Radisys will demonstrate the realization of true, converged broadband-everywhere networks powered by software-defined, disaggregated, Open RAN leveraging FTTX-based xHaul transport supported by automation, analytics monetization, and guaranteed assurance of service.
- Radisys will showcase its complete network lifecycle services – consult, design, build, integrate, operate, and optimize – across all of the network domains of today’s digital networks including the RAN, Optical/IP Transport, Core and Enterprise networks.
Monetization
- Radisys’ Smart Living Demonstration is made possible by Radisys’ Reach Smart Home that enables broadband service providers to increase customer stickiness and revenue by bundling smart home services with broadband plans. Use cases include comfort living, home security, safety and energy management. Radisys’ Smart Home Operator Dashboard brings insightful business KPIs for monetizing new services.
-
Radisys’ Digital Engagement showcase will highlight the video analytics capabilities of its Engage Platform, including mask detection and social distancing. Service providers can use these analytics to build specific applications such as biometric authentication and COVID policy enforcement.
- Attendees will have a personalized interaction with Radisys’ Engage Video Assistant (EVA) – the world’s first three-in-one AI-based video bot.
- Radisys will feature its newly launched Engage Digital Platform (EDP), a flexible, reliable and low code/no code Communications Platform-as-a-Service (CPaaS). Radisys will demonstrate the ease of use of the EDP Portal where admins and developers can create new services almost instantaneously via a drag and drop menu.
Leadership Presence
- Radisys and global service providers Deutsche Telekom and Reliance Jio will share their joint vision on disaggregated access during an interactive panel discussion taking place Tuesday, March 1 at 15:10-15:25 CET on the DT booth stage, Booth 3M31.
- Radisys is sponsoring the Open RAN Summit at MWC. Ganesh Shenbagaraman, head of integrated products and ecosystems, will participate on a panel discussion on “Open RAN Opportunity Use Cases” on March 2 from 2:30pm-3:30pm in CC3.13 Fira Gran Via.
- Radisys’ head of Mobility Software and Services, Munish Chhabra will participate in Xilinx’s 5G Leadership Power Hour Theater Session on March 2 from 9:30am-11:00am at the CET Theater 2 in Hall 7.
“Our theme for MWC is ‘Connectivity Reimagined, Experience Reimagined, Telco Reimagined’ and we are showing service provider and enterprise customers how our solutions can aid their network and business transformation with open platforms and architectures, and new innovative services and digital engagement solutions to reimagine their role as true digital engagement providers,” said Natasha Tamaskar, head of Global Marketing, Business Strategy and Digital Endpoints Business, Radisys. “Unlike other modern OEMs in the market, Radisys has a unique position as our portfolio covers both fixed and mobile access and leverages the global footprint of our media platform complemented by digital endpoints and services. Our solutions enable greater service opportunities and enhanced digital experiences for customers across the globe.”
To meet with Radisys’ experts at MWC Barcelona and learn more about innovations in Open RAN, broadband, and digital engagement, contact open@radisys.com .
About Radisys
Radisys, a global leader in open telecom solutions, enables service providers to drive disruption with new open architecture business models. Radisys’ innovative disaggregated and virtualized enabling technology solutions leverage open reference architectures and standards, combined with open software and hardware to power business transformation for the telecom industry, while its world-class services organization delivers systems integration expertise necessary to solve communications’ and content providers’ complex deployment challenges. For more information, visit www.Radisys.com .
Radisys® is a registered trademark of Radisys. All other trademarks are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220225005400/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom